Barclays PLC - Form 8.3 - HORIZON THERAPEUTICS PLC
|
FORM 8.3 |
|||||||
|
IRISH TAKEOVER PANEL |
|||||||
|
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, |
|||||||
|
TAKEOVER RULES, 2007 (AS AMENDED) |
|||||||
|
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES |
|||||||
|
REPRESENTING 1% OR MORE |
|||||||
|
1. |
KEY INFORMATION |
||||||
|
Name of person dealing (Note 1) |
Barclays PLC. |
||||||
|
Company dealt in |
HORIZON THERAPEUTICS PLC |
||||||
|
Class of relevant security to which the dealings being disclosed relate (Note 2) |
|
||||||
|
Date of dealing |
|
||||||
|
2. |
INTERESTS AND |
||||||
|
(a) |
Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) |
||||||
|
Class of relevant security: |
|
||||||
|
|
Long |
Short |
|||||
|
Number |
(%) |
Number |
(%) |
||||
|
(1) |
Relevant securities |
1,004,865 |
0.44% |
545,037 |
0.24% |
||
|
(2) |
Derivatives (other than options): |
140,756 |
0.06% |
98,064 |
0.04% |
||
|
(3) |
Options and agreements to purchase/sell: |
1,260,600 |
0.55% |
961,400 |
0.42% |
||
|
TOTAL: |
2,406,221 |
1.05% |
1,604,501 |
0.70% |
|||
|
(b) |
Interests and short positions in relevant securities of the company, other than the class dealt in |
||||||
|
Class of relevant security: |
Long |
Short |
|||||
|
Number |
(%) |
Number |
(%) |
||||
|
(1) |
Relevant securities |
|
|
|
|
||
|
(2) |
Derivatives (other than options): |
|
|
|
|
||
|
(3) |
Options and agreements to purchase/sell: |
|
|
|
|
||
|
TOTAL: |
|
|
|
|
|||
|
3. |
DEALINGS (Note 4) |
||||||
|
(a) |
Purchase and sales |
|
|
|
|
|
|
|
Class of relevant Security |
Purchase/sale |
Number of securities |
Price per unit |
||||
|
|
Purchase |
1 |
|
||||
|
|
Purchase |
4 |
|
||||
|
|
Purchase |
7 |
|
||||
|
|
Purchase |
8 |
|
||||
|
|
Purchase |
8 |
|
||||
|
|
Purchase |
11 |
|
||||
|
|
Purchase |
59 |
|
||||
|
|
Purchase |
60 |
|
||||
|
|
Purchase |
100 |
|
||||
|
|
Purchase |
100 |
|
||||
|
|
Purchase |
100 |
|
||||
|
|
Purchase |
100 |
|
||||
|
|
Purchase |
100 |
|
||||
|
|
Purchase |
110 |
|
||||
|
|
Purchase |
196 |
|
||||
|
|
Purchase |
200 |
|
||||
|
|
Purchase |
300 |
|
||||
|
|
Purchase |
311 |
|
||||
|
|
Purchase |
400 |
|
||||
|
|
Purchase |
403 |
|
||||
|
|
Purchase |
452 |
|
||||
|
|
Purchase |
475 |
|
||||
|
|
Purchase |
481 |
|
||||
|
|
Purchase |
568 |
|
||||
|
|
Purchase |
847 |
|
||||
|
|
Purchase |
906 |
|
||||
|
|
Purchase |
1,305 |
|
||||
|
|
Purchase |
2,443 |
|
||||
|
|
Purchase |
2,550 |
|
||||
|
|
Purchase |
2,832 |
|
||||
|
|
Purchase |
3,252 |
|
||||
|
|
Purchase |
3,392 |
|
||||
|
|
Purchase |
3,760 |
|
||||
|
|
Purchase |
7,505 |
|
||||
|
|
Purchase |
7,597 |
|
||||
|
|
Purchase |
10,037 |
|
||||
|
|
Purchase |
12,549 |
|
||||
|
|
Purchase |
12,892 |
|
||||
|
|
Purchase |
16,359 |
|
||||
|
|
Purchase |
19,174 |
|
||||
|
|
Purchase |
23,754 |
|
||||
|
|
Purchase |
26,718 |
|
||||
|
|
Purchase |
75,000 |
|
||||
|
|
Purchase |
79,000 |
|
||||
|
|
Purchase |
88,448 |
|
||||
|
|
Purchase |
90,000 |
|
||||
|
|
Sale |
1 |
|
||||
|
|
Sale |
2 |
|
||||
|
|
Sale |
2 |
|
||||
|
|
Sale |
2 |
|
||||
|
|
Sale |
7 |
|
||||
|
|
Sale |
8 |
|
||||
|
|
Sale |
50 |
|
||||
|
|
Sale |
51 |
|
||||
|
|
Sale |
100 |
|
||||
|
|
Sale |
100 |
|
||||
|
|
Sale |
100 |
|
||||
|
|
Sale |
100 |
|
||||
|
|
Sale |
107 |
|
||||
|
|
Sale |
110 |
|
||||
|
|
Sale |
122 |
|
||||
|
|
Sale |
127 |
|
||||
|
|
Sale |
140 |
|
||||
|
|
Sale |
155 |
|
||||
|
|
Sale |
198 |
|
||||
|
|
Sale |
200 |
|
||||
|
|
Sale |
200 |
|
||||
|
|
Sale |
200 |
|
||||
|
|
Sale |
201 |
|
||||
|
|
Sale |
202 |
|
||||
|
|
Sale |
303 |
|
||||
|
|
Sale |
310 |
|
||||
|
|
Sale |
325 |
|
||||
|
|
Sale |
335 |
|
||||
|
|
Sale |
350 |
|
||||
|
|
Sale |
365 |
|
||||
|
|
Sale |
410 |
|
||||
|
|
Sale |
507 |
|
||||
|
|
Sale |
532 |
|
||||
|
|
Sale |
546 |
|
||||
|
|
Sale |
600 |
|
||||
|
|
Sale |
800 |
|
||||
|
|
Sale |
822 |
|
||||
|
|
Sale |
1,001 |
|
||||
|
|
Sale |
1,019 |
|
||||
|
|
Sale |
1,064 |
|
||||
|
|
Sale |
1,100 |
|
||||
|
|
Sale |
1,107 |
|
||||
|
|
Sale |
1,151 |
|
||||
|
|
Sale |
1,200 |
|
||||
|
|
Sale |
1,310 |
|
||||
|
|
Sale |
1,461 |
|
||||
|
|
Sale |
1,699 |
|
||||
|
|
Sale |
1,799 |
|
||||
|
|
Sale |
1,947 |
|
||||
|
|
Sale |
2,206 |
|
||||
|
|
Sale |
2,566 |
|
||||
|
|
Sale |
2,571 |
|
||||
|
|
Sale |
4,015 |
|
||||
|
|
Sale |
6,098 |
|
||||
|
|
Sale |
7,097 |
|
||||
|
|
Sale |
7,554 |
|
||||
|
|
Sale |
11,068 |
|
||||
|
|
Sale |
11,853 |
|
||||
|
|
Sale |
19,591 |
|
||||
|
|
Sale |
22,753 |
|
||||
|
|
Sale |
31,713 |
|
||||
|
|
Sale |
59,474 |
|
||||
|
|
Sale |
88,348 |
|
||||
|
|
Sale |
90,000 |
|
||||
|
|
Sale |
93,390 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(b) |
Derivatives transactions (other than option transactions) |
||||||
|
Product Name |
Nature of transaction |
Number of relevant securities |
Price per unit |
||||
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(c) |
Options transactions in respect of existing securities |
||||||
|
(i) |
Writing, selling, purchasing or varying |
||||||
|
Class |
Product |
Writing, |
Number |
Exercise |
Type |
Expiry |
Option |
|
|
Put Options |
Purchasing |
143,900 |
|
American |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii) |
Exercising |
|
|
|
|
|
|
|
Product name |
Number of |
Exercise price |
|||||
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(d) |
Other dealings (including transactions in respect of new securities) (Note 4) |
||||||
|
Nature of transaction |
Details |
Price per unit |
|||||
|
|
|
|
|||||
|
4. |
OTHER INFORMATION |
||||||
|
Agreements, arrangements or understandings relating to options or derivatives |
|||||||
|
Full details of any agreement, arrangement or understanding between the person disclosing |
|||||||
|
NONE |
|||||||
|
Is a Supplemental Form 8 (Open Positions) attached? |
YES |
||||||
|
Date of disclosure: |
|
||||||
|
Contact name: |
Large Holdings Regulatory Operations |
||||||
|
Telephone number: |
020 3134 7213 |
||||||
|
If a connected EFM, name of offeree/offeror with which connected |
|
||||||
|
If a connected EFM, state nature of connection |
|
||||||
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL FORM 8 |
|||||||
|
|
|
|
|
|
|
|
|
|
IRISH TAKEOVER PANEL |
|||||||
|
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL |
|||||||
|
ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED) |
|||||||
|
DETAILS OF OPEN POSITIONS |
|||||||
|
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as |
|||||||
|
appropriate) |
|||||||
|
OPEN POSITIONS |
|
|
|
|
|
|
|
|
Class of relevant |
Product |
Writing, |
Number |
Exercise |
Type |
Expiry |
|
|
|
Put Options |
Written |
495,500 |
100 |
American |
|
|
|
|
Call Options |
Written |
-25,000 |
115 |
American |
|
|
|
|
Put Options |
Written |
28,800 |
095 |
American |
|
|
|
|
Call Options |
Written |
-10,600 |
105 |
American |
|
|
|
|
Put Options |
Written |
2,000 |
085 |
American |
|
|
|
|
Put Options |
Purchased |
-250,000 |
080 |
American |
|
|
|
|
Put Options |
Written |
10,200 |
080 |
American |
|
|
|
|
Put Options |
Written |
88,100 |
105 |
American |
|
|
|
|
Call Options |
Written |
-2,000 |
100 |
American |
|
|
|
|
Call Options |
Written |
-2,600 |
100 |
American |
|
|
|
|
Put Options |
Written |
74,000 |
090 |
American |
|
|
|
|
Put Options |
Written |
400,000 |
100 |
American |
|
|
|
|
Put Options |
Purchased |
-544,200 |
080 |
American |
|
|
|
|
Put Options |
Written |
162,000 |
105 |
American |
|
|
|
|
Put Options |
Purchased |
-106,800 |
090 |
American |
|
|
|
|
Call Options |
Written |
-10,000 |
105 |
American |
|
|
|
|
Put Options |
Purchased |
-10,200 |
100 |
American |
|
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
This content is published by Proactive Investors Limited and made available subject to the terms and conditions of use of its website (see Terms of Use).
Proactive Investors is a full-service financial newswire. We produce independent, objective financial journalism and do not provide personalised investment advice, act as a broker, or recommend specific securities to individual investors.
Financial content published on this Site is produced under the journalist exemption provided for in Article 20 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, and in accordance with FCA guidance at PERG 8.12. Where a communication is not otherwise exempt, it is issued or approved for distribution in the UK by Proactive Investors Limited.
All information used in the preparation of this communication has been compiled from publicly available sources that we believe to be reliable, however, we cannot, and do not, guarantee the accuracy or completeness of this communication.
This communication is intended for information purposes only and does not constitute investment advice, a personal recommendation, an offer, solicitation, or inducement to buy or sell any investment or financial product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
This communication has been prepared without taking account of the objectives, financial situation or needs of any particular investor. Before entering into any transaction, investors should consider suitability for their individual circumstances and should read the relevant prospectus, term sheet, subscription agreement, information memorandum, prospectus or other offering document in full.
Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise, and you may not recover the amount you invest.
This communication may contain information obtained from third parties, including credit ratings and financial data. Reproduction and distribution of third-party content in any form is prohibited except with the prior written consent of the relevant third party. Credit ratings are statements of opinion and should not be relied upon as investment advice.
FOR OUR FULL DISCLAIMER CLICK HERE